Suchergebnisse - "Capparelli, Edmund V"

PubPharm (13)

1

Phase 1 trial evaluating safety and pharmacokinetics of HIV-1 broadly neutralizing mAbs 10E8VLS and VRC07-523LS

enthalten in: JCI insight | 2024

von Awan, S. | Pegu, A. | Strom, L. | +34

2

Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C) : a phase 1, adaptive trial

enthalten in: The Lancet. Infectious diseases | 2023

von Lyke, K. | Berry, A. | Mason, K. | +98

CommentIn: Lancet Infect Dis. 2023 May;23(5):514-516. - PMID 36708739

3

Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B) : a phase 1, dose-escalation, randomised controlled trial

enthalten in: The lancet. HIV | 2023

von Mahomed, S. | Garrett, N. | Capparelli, E. | +18

CommentIn: Lancet HIV. 2023 Apr;10(4):e211-e212. - PMID 37001961

4

Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention

enthalten in: The Journal of infectious diseases | 2022

von Mahomed, S. | Garrett, N. | Capparelli, E. | +19

5

Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria

enthalten in: The New England journal of medicine | 2022

von Wu, R. | Idris, A. | Berkowitz, N. | +127

CommentIn: N Engl J Med. 2022 Aug 4;387(5):460-461. - PMID 35921456

6

Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn Infants

enthalten in: The Journal of infectious diseases | 2021

von McFarland, E. | Cunningham, C. | Muresan, P. | +47

7

A Monoclonal Antibody for Malaria Prevention

enthalten in: The New England journal of medicine | 2021

von Gaudinski, M. | Berkowitz, N. | Idris, A. | +136

CommentIn: Med. 2021 Nov 12;2(11):1198-1200. - PMID 35590195

8

Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics Approach

enthalten in: Clinical pharmacology and therapeutics | 2021

von Li, J. | Nikanjam, M. | Cunningham, C. | +12

9

Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing Human Immunodeficiency Virus (HIV)-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants

enthalten in: The Journal of infectious diseases | 2020

von Cunningham, C. | McFarland, E. | Morrison, R. | +64

CommentIn: J Infect Dis. 2020 Jul 23;222(4):525-527. - PMID 31681956

10

Population pharmacokinetics of siltuximab : impact of disease state

enthalten in: Cancer chemotherapy and pharmacology | 2019

von Nikanjam, M. | Yang, J. | Capparelli, E.